Vontron Technology(000920)
Search documents
沃顿科技:截至2025年11月28日公司股东数量为27846户
Zheng Quan Ri Bao· 2025-12-05 15:43
证券日报网讯 12月5日,沃顿科技在互动平台回答投资者提问时表示,截至2025年11月28日,公司股东 数量为27846户。 (文章来源:证券日报) ...
沃顿科技最新股东户数环比下降5.09% 筹码趋向集中
Zheng Quan Shi Bao Wang· 2025-12-05 09:07
公司发布的三季报数据显示,前三季公司共实现营业收入13.82亿元,同比增长19.72%,实现净利润 1.95亿元,同比增长29.21%,基本每股收益为0.4130元,加权平均净资产收益率9.89%。(数据宝) 沃顿科技12月5日披露,截至11月30日公司股东户数为27846户,较上期(11月20日)减少1494户,环比 降幅为5.09%。这已是该公司股东户数连续第2期下降。 证券时报·数据宝统计,截至发稿,沃顿科技收盘价为12.09元,上涨0.33%,本期筹码集中以来股价累 计下跌9.03%。具体到各交易日,4次上涨,6次下跌。 (文章来源:证券时报网) ...
沃顿科技:超纯水业务目前在整体营业收入中的占比较小
Ge Long Hui· 2025-12-05 08:25
格隆汇12月5日丨沃顿科技(000920.SZ)在互动平台表示,公司超纯水业务目前在整体营业收入中的占比 较小,由于该行业对膜产品具有较高的技术与品质要求,公司超纯水系列膜产品毛利率高于公司膜产品 的平均毛利率。 ...
沃顿科技(000920.SZ):超纯水业务目前在整体营业收入中的占比较小
Ge Long Hui· 2025-12-05 08:20
格隆汇12月5日丨沃顿科技(000920.SZ)在互动平台表示,公司超纯水业务目前在整体营业收入中的占比 较小,由于该行业对膜产品具有较高的技术与品质要求,公司超纯水系列膜产品毛利率高于公司膜产品 的平均毛利率。 ...
沃顿科技(000920.SZ):质子交换膜是公司前瞻性研究领域之一,目前处于基础研究和试验性生产阶段
Ge Long Hui· 2025-11-28 08:30
格隆汇11月28日丨沃顿科技(000920.SZ)在投资者互动平台表示,质子交换膜是公司前瞻性研究领域之 一,目前处于基础研究和试验性生产阶段,作为技术储备项目,是否产业化存在不确定性。 ...
盐湖提锂板块震荡下跌 倍杰特、争光股份跌超6%
Mei Ri Jing Ji Xin Wen· 2025-11-26 02:28
Core Viewpoint - The lithium extraction sector in the salt lake region is experiencing significant volatility, with several companies seeing substantial declines in their stock prices [1] Company Performance - Beijite and Zhengguang Co. both experienced declines exceeding 6% [1] - Other companies such as China Electric Environmental Protection, Jiuwu High-Tech, Zhongwei Co., Walton Technology, and Guoji General also saw their stock prices decrease [1]
11月25日晚间重要公告一览
Xi Niu Cai Jing· 2025-11-25 10:16
分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]
沃顿科技:拟以自有资金3亿元投资设立全资子公司沃顿科技(南京)有限公司
Mei Ri Jing Ji Xin Wen· 2025-11-24 16:38
每经头条(nbdtoutiao)——大鹏工业战略配售"肥"了自家人!认购价9元,上市首日涨到118元,实控 人和亲哥哥凭配售一天浮盈2492万元 (记者 曾健辉) 2025年1至6月份,沃顿科技的营业收入构成为:特殊化学品制造占比62.64%,植物纤维制品制造业占 比22.95%,膜分离占比9.35%,中水回用占比3.85%,其他业务占比1.21%。 截至发稿,沃顿科技市值为58亿元。 每经AI快讯,沃顿科技(SZ 000920,收盘价:12.2元)11月24日晚间发布公告称,沃顿科技股份有限 公司于2025年11月21日召开第八届董事会第九次会议,审议通过了《关于投资设立全资子公司的议 案》,公司拟以自有资金3亿元投资设立全资子公司沃顿科技(南京)有限公司。根据《深圳证券交易 所股票上市规则》、《公司章程》等相关规定,本事项无需提交股东会审议。本事项不构成关联交易, 也不属于《上市公司重大资产重组管理办法》规定的重大资产重组。 ...
沃顿科技(000920.SZ):拟3亿元设立全资子公司
Ge Long Hui A P P· 2025-11-24 13:55
Core Viewpoint - Wharton Technology (000920.SZ) has approved the establishment of a wholly-owned subsidiary, Wharton Technology (Nanjing) Co., Ltd., with an investment of 300 million yuan from its own funds [1] Group 1 - The eighth board of directors' ninth meeting was held to review the proposal for the investment [1] - The investment amount for the new subsidiary is set at 30,000,000 yuan [1]
沃顿科技拟3亿元投设南京沃顿 投资运营膜用材料及膜组件能力提升项目
Zhi Tong Cai Jing· 2025-11-24 11:55
Core Viewpoint - Wharton Technology (000920.SZ) plans to invest 300 million yuan to establish a wholly-owned subsidiary, Wharton Technology (Nanjing) Co., Ltd., which will focus on enhancing the company's membrane materials and membrane components capabilities [1] Group 1 - The investment amount for the establishment of the subsidiary is 300 million yuan [1] - The new subsidiary, Nanjing Wharton, will serve as the investment and operational entity for the membrane materials and components enhancement project [1] - The project is currently in the planning stage [1]